Nutrition and health - Favourable effect of wine and wine flavonoids on cardiovascular diseases;Voeding en gezondheid - Gunstig effect van wijn en wijnflavonoïden op hart- en vaatziekten

Nederlands Tijdschrift voor Geneeskunde

Volumn 146, Issue 51, 2002, Pages 2466-2469

  Van De Wiel, A ^a  

^a MEANDER MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; POLYPHENOL; PROSTAGLANDIN;

ALCOHOLIC BEVERAGE; ANTIOXIDANT ACTIVITY; ARTICLE; BIOAVAILABILITY; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; GRAPE; HEALTH PROMOTION; HUMAN; LIPID OXIDATION; NUTRITION; PROSTAGLANDIN SYNTHESIS INHIBITION; THROMBOCYTE AGGREGATION INHIBITION; WINE;

ALCOHOL DRINKING; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; FLAVONOIDS; HUMANS; OXIDATION-REDUCTION; PHENOLS; POLYMERS; VITIS; WINE;

EID: 0037153676     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Soleas GJ, Diamandis EP, Goldberg DM. Wine as a biological fluid: History, production, and role in disease prevention. J Clin Lab Anal 1997;11:287-313.
2. Wiel A van de, Poppelier A, Dalen WE van, Mheen D van de. Hoeveel alcohol is te veel en waarom? Kanttekeningen bij sociaal geaccepteerd overmatig alcoholgebruik. Ned Tijdschr Geneeskd 2002;146:2463-5.
3. St Leger AS, Cochrane AL, Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1979;1(8124):1017-20.
4. Grønbáek M, Deis A, Sørensen TIA, Becker U, Borch-Johnsen K, Muller C, et al. Influence of sex, age, body mass index, and smoking on alcohol intake and mortality. BMJ 1994;308:302-6.
5. Renaud S, de Lorgeril M. Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet 1992;339:1523-6.
6. Cleophas TI. Wine, beer and spirits and the risk of myocardial infarction: A systematic review. Biomed Pharmacother 1999;53:417-23.
7. Rimm EB, Klatsky AL, Grobbee D, Stampfer MJ. Review of moderate alcohol consumption and reduced risk of coronary heart disease: Is the effect due to beer, wine, or spirits? BMJ 1996;312:731-6.
8. Grønbáek M. Type of alcohol and mortality from cardiovascular disease. Food Chem Toxicol 1999;37:921-4.
9. Albert CM, Manson JE, Cook NR, Ajani UA, Gaziano JM, Hennekens CH. Moderate alcohol consumption and the risk of sudden death among U.S. male physicians. Circulation 1999;100:944-50.
10. Berger K, Ajani UA, Kase CS, Gaziano JM, Buring JE, Glynn RJ, et al. Light-to-moderate alcohol consumption and the risk of stroke among U.S. male physicians. N Engl J Med 1999;341:1557-64.
11. Ruitenberg A, Swieten JC van, Witteman JCM, Mehta KM, Duijn CM van, Hofman A, et al. Alcohol consumption and risk of dementia: The Rotterdam Study. Lancet 2002;359:281-6.
12. Suh I, Shaten BJ, Cutler JA, Kuller LH. Alcohol use and mortality from coronary heart disease: The role of high-density lipoprotein cholesterol. The Multiple Risk Factor Intervention Trial Research Group. Ann Intern Med 1992;116:881-7.
13. Välimäki M, Taskinen MR. Effects of different doses of alcohol on serum lipoproteins. In: Veenstra J, Heij DG van der, editors. Alcohol and Cardiovascular Disease. Wageningen: Pudoc; 1992. p. 75-86.
14. Hines LM, Stampfer MJ, Ma J, Gaziano JM, Ridker PM, Hankinson ME, et al. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med 2001;344:549-55.
15. Wiel A van de. Alcohol and insulin sensitivity. Neth J Med 1998;52:91-4.
16. Mukamal KJ, Jadhav PP, D'Agostino RB, Massaro JM, Mittleman MA, Lipinska I, et al. Alcohol consumption and hemostatic factors: Analysis of the Framingham offspring cohort. Circulation 2001;104:1367-73.
17. Wiel A van de, Golde PM van, Kraaijenhagen RJ, Borne PA von dem, Bouma BN, Hart HC. Acute inhibitory effect of alcohol on fibrinolysis. Eur J Clin Invest 2001;31:164-70.
18. Booyse FM, Parks DA. Moderate wine and alcohol consumption: Beneficial effects on cardiovascular disease. Thromb Haemost 2001;86:517-28.
19. Lairon D, Amiot MJ. Flavonoids in food and natural antioxidants in wine. Curr Opin Lipidol 1999;10:23-8.
20. Hollman PCH, Gaag M van der, Mengelers MJB, Trijp JMP van, Vries JHM de, Katan MB. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radic Biol Med 1996;21:703-7.
21. Teissedre PL, Frankel EN, Waterhouse AL, Peleg H, German JB. Inhibition of in vitro human LDL oxidation by phenolic antioxidants from grapes and wines. J Sci Food Agric 1996;70:55-61.
22. Steinburg D, Parthasarathy S, Carew TE, Khoo JC, Witzturn JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
23. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993;341:454-7
24. Golde PHM van, Sloots LM, Vermeulen WP, Wielders JPM, Hart HC, Bouma BN, et al. The role of alcohol in the anti low-density lipoprotein oxidation activity of red wine. Atherosclerosis 1999;147:365-70.
25. Wiel A van de, Golde PHM van, Hart HC. Blessings of the grape. Eur J Intern Med 2001;12:484-9.
26. Vries JH de, Hollman PC, Amersfoort I van, Olthof MR, Katan MB. Red wine is a poor source of bioavailable flavonols in men. J Nutr 2001;131:745-8.
27. Demrow HS, Slane PR, Folts JD. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation 1995;91:125-31.
28. Fitzpatrick DF, Hirschfield SL, Coffey RG. Endothelium-dependent vasorelaxing activity of wine and other grape products. Am J Physiol 1993;265(2 Pt 2):774-8.
29. Agewall S, Wright S, Doughty RN, Whalley GA, Duxbury M, Sharpe N. Does a glass of red wine improve endothelial function? Eur Heart J 2000;21:74-8.
30. Serebruany LV, Lowry DR. GUSTO-III Platelet Study. Take an aspirin or have a drink; antecedent aspirin and moderate alcohol consumption similarly affect baseline platelet characteristics in patients with acute myocardial infarction. Thromb Haemost 2000;84:933-4.
31. Hertog MGL, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 1995;155:381-6.
32. Diaz MN, Frei B, Vita JA, Keaney jr JF. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997;337:408-16.